Find your next paid study

Wake Forest University Health SciencesNCT06746753

Phase 4

ANGIOtensin II for Septic Shock in the Emergency Department: ANGIO-ED Study

This pilot study will enroll 20 patients with septic shock and require emergent vasopressor support in the emergency department (ED). The primary objective of …

Septic Shock

~$10 – $7,500

Brett A FaineNCT06693726

Phase 4

Clinical Decision Support Assistance to Randomize Patients to Early or Late Adjunctive Vasopressin in Septic Shock

The goal of the CASPER-Pilot study is to develop clinical decision support (CDS) technology within Epic to randomize patients with septic shock to early versus…

SepsisSeptic Shock

The Cleveland ClinicNCT06709573

Personalized Fluid Resuscitation for Improved Sepsis Resuscitation Quality in the Emergency Department

The goal of this pilot clinical trial is to learn if a fluid assessment using non-invasive cardiac output monitoring (NICOM) is helpful for patients with sepsi…

SepsisSeptic Shock

Intermountain Health Care, Inc.NCT07779720

~$10 – $8,750

Immune Dysregulation During Sepsis: A Natural History Cohort

Background: Sepsis is an illness that occurs when the body s immune system runs out of control. This can damage organs. Sepsis causes an estimated 1 in 5 deat…

SepsisSeptic ShockSepsis-Associated Immune Dysregulation

National Heart, Lung, and Blood Institute (NHLBI)NCT07735741

~$10 – $675

Sepsis SevereSeptic Shock

Assessment for Implementation Methods in Sepsis

Since the introduction of sepsis bundles, there have been multiple published trials that have demonstrated a consistent, strong association between implementat…

Rhode Island HospitalNCT05491941

Phase 3

A Phase III, Open Label, Randomized, Controlled Study of VBI-S in the Treatment of Hypovolemia in Patients With Septic Shock

This study is being conducted to evaluate the safety and effectiveness of VBI-S in elevating the blood pressure of septic shock patients with absolute or relat…

Septic ShockSepsisHypovolemia

~$10 – $7,500

Vivacelle BioNCT06072430

SepsisSepsis MrsaSepsis Bacteremia+4 more

Reducing Empiric VAncomycin Use in Pediatric Suspected Sepsis (REVAMP-Sepsis)

The goal of this quasi-experimental interventional study is to determine the effectiveness of a multifaceted stewardship intervention in reducing overall vanco…

Children's Hospital of PhiladelphiaNCT05975671

Role of Transposable Elements in Septic Immune Aging

The goal of this observational study is to learn about how transposable element levels affect the patient outcomes in sepsis. The main questions it aims to ans…

SepsisSepsis and Septic ShockSepsis With Multiple Organ Dysfunction (MOD)+5 more

University of California, San FranciscoNCT06809868

~$10 – $675

Alveolar Dead Space as Predictor of Multi-organ Failure and Mortality in Medical Intensive Care Patients With Sepsis Requiring Mechanical Ventilation

This is an observational study to understand the changes in alveolar dead space in medical critically ill patients with severe infection (severe sepsis) requir…

SepsisSevere SepsisSeptic Shock+1 more

The University of Texas Health Science Center, HoustonNCT01315782

~$10 – $750

Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis

Sepsis is life-threatening organ dysfunction caused by a dysregulated host response to infection. It is the most expensive healthcare condition to treat in Uni…

Septic Shock

University of OklahomaNCT03992378

Phase 4

An Open-label, Single-arm, Single-center Study Evaluating the Hemodynamic Response to Angiotensin-II When Used as the Second Vasopressor Agent for Septic Shock

Norepinephrine is a catecholamine that is the first-line vasopressor for septic shock. The addition of non-catecholamine vasopressors, including vasopressin an…

Septic ShockShockSepsis+1 more